![](https://netrf.org/wp-content/uploads/2022/04/NewClinicalTrialTestingChemotherapy-300x207.jpg)
New Clinical Trial Testing Chemotherapy After Surgery in High-Risk pNETs
A new phase II clinical trial is exploring the effects of two approved chemotherapy drugs administered after surgery to treat adult patients who have high-risk, well-differentiated pancreatic neuroendocrine tumors (pNETS).